Hydrochloric Acid → 4-{[(2S)-2-Hydroxy-3-(9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)propyl]-oxy}benzonitrile

HRID 500467노트

반응식

HRID 500467 반응식
[C:1]([C:3]1[CH:29]=[CH:28][C:6]([O:7][CH2:8][C@@H:9]([OH:27])[CH2:10][N:11]2[CH2:18][CH:17]3[O:19][CH:13]([CH2:14][N:15](C(OC(C)(C)C)=O)[CH2:16]3)[CH2:12]2)=[CH:5][CH:4]=1)#[N:2].Cl>C(OCC)(=O)C>[OH:27][C@@H:9]([CH2:10][N:11]1[CH2:18][CH:17]2[O:19][CH:13]([CH2:14][NH:15][CH2:16]2)[CH2:12]1)[CH2:8][O:7][C:6]1[CH:28]=[CH:29][C:3]([C:1]#[N:2])=[CH:4][CH:5]=1

참가 물질

4

실험 절차

A solution of tert-butyl 7-[(2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate (from step (ii) above; 1.0 g, 2.47 mmol) in ethyl acetate (13 mL) was cooled to 0° C. Ethyl acetate (26 mL) saturated with gaseous HCl was added, and the mixture stirred for 4 h at rt. The solvent was removed in vacuo before MeCN (25 mL), water (1.3 mL) and K2CO3 (2.0 g) were added. The resulting mixture was stirred overnight before CHCl3 was added, and the mixture filtered through Celite®. The filtrate was concentrated in vacuo to give 682 mg (91%) of the title compound.

후처리

  1. customThe solvent was removed in vacuo before MeCN (25 mL), water (1.3 mL) and K2CO3 (2.0 g)
  2. additionwere added
  3. stirringThe resulting mixture was stirred overnight before CHCl3
  4. additionwas added
  5. filtrationthe mixture filtered through Celite®
  6. concentrationThe filtrate was concentrated in vacuo

출처 및 근거

ORD 기록
ord-e1a201d4a623495480406f6f5a092599
출처 데이터셋
uspto-grants-2010_08
특허 번호
US07772229B2

반응 노트

불러오는 중…